Fonte: Journal of the Serbian Chemical Society. Unidades: FCFRP, FFCLRP
Assuntos: DIIDROTESTOSTERONA, RECEPTORES ANDROGÊNICOS, TRIAGEM, NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Raí et al. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity. Journal of the Serbian Chemical Society, v. 84, n. 2, p. 153-174, 2019Tradução . . Disponível em: https://doi.org/10.2298/jsc180129047s. Acesso em: 02 ago. 2024.APA
Silva, R., Poiani, J. G. C., Ramos, R. S., Costa, J. S., Silva, C. H. T. de P. da, Brasil, D. S. B., & Santos, C. B. R. (2019). Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity. Journal of the Serbian Chemical Society, 84( 2), 153-174. doi:10.2298/jsc180129047sNLM
Silva R, Poiani JGC, Ramos RS, Costa JS, Silva CHT de P da, Brasil DSB, Santos CBR. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity [Internet]. Journal of the Serbian Chemical Society. 2019 ; 84( 2): 153-174.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2298/jsc180129047sVancouver
Silva R, Poiani JGC, Ramos RS, Costa JS, Silva CHT de P da, Brasil DSB, Santos CBR. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity [Internet]. Journal of the Serbian Chemical Society. 2019 ; 84( 2): 153-174.[citado 2024 ago. 02 ] Available from: https://doi.org/10.2298/jsc180129047s
